Juan-Francisco Peña-Cardelles

Dr. Juan-Francisco Peña-Cardelles

Universidad Rey Juan carlos
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Clinical and Experimental Dentistry
Verified
Journal Article
Open access
DOD Ortega-Concepcion
D Ortega-Concepcion
JCJa Cano-Duran
Ja Cano-Duran
Juan-Francisco Peña-CardellesJuan-Francisco Peña-Cardelles
Juan-Francisco Peña-Cardelles
VPVm Paredes-Rodriguez
Vm Paredes-Rodriguez
JGJosé González-Serrano
José González-Serrano
JLJ Lopez-Quiles
J Lopez-Quiles
Since its appearance in the dental area, the laser has become a treatment of choice in the removal of lesions in the oral soft tissues, due to the numerous advantages they offer, being one of the most used currently the diode laser. The aim of this review was to determine the efficacy and predictability of diode laser as a treatment of soft tissue injuries compared to other surgical methods. A literature review of articles published in PubMed/MEDLINE, Scopus and the Cochrane Library databases between 2007 and 2017 was performed. "Diode laser", "soft tissue", "oral cavity" and "oral surgery" were employed for the search strategy. Only articles published English or Spanish were selected. The diode laser is a minimally invasive technology that offers great advantages, superior to those of the conventional scalpel, such as reduction of bleeding, inflammation and the lower probability of scars. Its effectiveness is comparable to that of other types of lasers, in addition to being an option of lower cost and greater ease of use. Its application in the soft tissues has been evaluated, being a safe and effective method for the excision of lesions like fibromas, epulis fissuratum and the accomplishment of frenectomies. The diode laser can be used with very good results for the removal of lesions in soft tissues, being used in small exophytic lesions due to their easy application, adequate coagulation, no need to suture and the slightest inflammation and pain. Key words:Diode laser, soft tissues, oral cavity, oral surgery.

8 March 2022 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
JSJavier Sicilia-Pasos
Javier Sicilia-Pasos
NKNARESH KEWALRAMANI
NARESH KEWALRAMANI
Juan-Francisco Peña-CardellesJuan-Francisco Peña-Cardelles
Juan-Francisco Peña-Cardelles
Angel-Orion Salgado-PeralvoAngel-Orion Salgado-Peralvo
Angel-Orion Salgado-Peralvo
MCMADRIGAL CRISTINA
MADRIGAL CRISTINA
ÁLÁngel López-Carpintero
Ángel López-Carpintero

1 February 2022 in Journal of Stomatology Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
Angel-Orion Salgado-PeralvoAngel-Orion Salgado-Peralvo
Angel-Orion Salgado-Peralvo
MMMaría-Victoria Mateos-Moreno
María-Victoria Mateos-Moreno
Eugenio Velasco-OrtegaEugenio Velasco-Ortega
Eugenio Velasco-Ortega
Juan-Francisco Peña-CardellesJuan-Francisco Peña-Cardelles
Juan-Francisco Peña-Cardelles
NKNARESH KEWALRAMANI
NARESH KEWALRAMANI

1 January 2017 in Journal of Clinical and Experimental Dentistry
Verified
Journal Article
Open access
JCJa Cano-Duran
Ja Cano-Duran
Juan-Francisco Peña-CardellesJuan-Francisco Peña-Cardelles
Juan-Francisco Peña-Cardelles
DOD Ortega-Concepcion
D Ortega-Concepcion
VPVm Paredes-Rodriguez
Vm Paredes-Rodriguez
MGM Garcia-Riart
M Garcia-Riart
JLJ Lopez-Quiles
J Lopez-Quiles
For the treatment of the bisphosphonates and other drugs related osteonecrosis of the jaws, currently medication-related osteonecrosis of the jaws (MRONJ), have been established different conservative therapeutic approaches, avoiding surgery except in cases of extreme need. Given the controversy and lack of current consensus regarding MRONJ therapy in patients, new techniques have been developed among which the use of fibrin membranes rich in platelets and leukocytes (L-PRF). The objective of this review is to evaluate whether L-PRF treatment is really effective, as well as the results that can be achieved by this therapeutic alternative. A review of the literature in the PubMed/Medline database of all those studies using L-PRF in the treatment of osteonecrosis using the keywords "Osteonecrosis", "Jaws", "L-PRF" and " Leucocyte-rich platelet-rich fibrin ". The use of L-PRF for the treatment of MRONJ is really effective, especially when it is performed with a simultaneous application of L-PRF and morphogenetic protein-2 (BMP-2), even in patients submitted for long periods of time to therapy with intravenous bisphosphonates. However, success will depend on several factors such as the previous existence of infection or the clinical stage in which the patient is. The current literature demonstrates the effectiveness of the use of L-PRF in osteonecrosis, and it can be considered as a real alternative in the treatment of this entity. However, more clinical studies are needed to really assess this new therapy. Key words:Osteonecrosis, Jaws, L-PRF, Leucocyte-rich platelet-rich fibrin.

22 December 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
Angel-Orion Salgado-PeralvoAngel-Orion Salgado-Peralvo
Angel-Orion Salgado-Peralvo
Juan-Francisco Peña-CardellesJuan-Francisco Peña-Cardelles
Juan-Francisco Peña-Cardelles
NKNARESH KEWALRAMANI
NARESH KEWALRAMANI
MMMaría-Victoria Mateos-Moreno
María-Victoria Mateos-Moreno
ÁJÁlvaro Jiménez-Guerra
Álvaro Jiménez-Guerra
LMLoreto Monsalve-Guil
Loreto Monsalve-Guil
Immediate implants present a high risk of early failure. To avoid this, preventive antibiotics (PAs) are prescribed; however, their inappropriate administration leads to antimicrobial resistance. The present study aims to clarify whether the prescription of PAs reduces the rate of early failure of immediate implants and to establish guidelines to avoid the overprescription of these drugs. An electronic search of the MEDLINE database (via PubMed), Web of Science, Scopus, LILACS and OpenGrey was carried out. The criteria described in the PRISMA® statement were used. The search was temporarily restricted from 2010 to 2021. The risk of bias was analysed using the SIGN Methodological Assessment Checklist for Systematic Reviews and Meta-Analyses and the JBI Prevalence Critical Appraisal Tool. After searching, eight studies were included that met the established criteria. With the limitations of this study, it can be stated that antibiotic prescription in immediate implants reduces the early failure rate. Preoperative administration of 2–3 g amoxicillin one hour before surgery followed by 500 mg/8 h for five to seven days is recommended. It is considered prudent to avoid the use of clindamycin in favour of azithromycin, clarithromycin or metronidazole in penicillin allergy patients until further studies are conducted.

1 January 2025 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Juan-Francisco Peña-CardellesJuan-Francisco Peña-Cardelles
Juan-Francisco Peña-Cardelles
JMJ. Markovic
J. Markovic
SAS. Akhondi
S. Akhondi
IPI. Pedrinaci
I. Pedrinaci
ALA. Lanis
A. Lanis
GGGo. Gallucci
Go. Gallucci
A concern associated with implant placement is the potential occurrence of neurovascular lesions and subsequent development of sensory alterations in patients undergoing implant placements. The objective of this review is to evaluate the incidence of neurosensory alterations based on the proximity between the implant and the mandibular canal Material and Methods: A systematic review was conducted in MEDLINE, Web of Science, and Scopus. Studies with common variables were selected to conduct a meta-analysis. The patient classification was based on the mandibular canal-implant distance. Neurosensory alteration percentages were calculated for each study and group. The findings indicate significant correlations between implant placement proximity and neurosensory risks. The incidence of neurosensory alterations in patients with implants placed at a distance ≥ 2 mm from the mandibular canal was 0%. Similarly, for distances between 1-2 mm from the mandibular canal, the incidence remained at 0%. However, for implants placed at a distance of 0-1 mm from the mandibular canal, the incidence of neurosensory alterations was 68%. Additionally, patients with implants that intruded into the canal had an incidence of 53% in the development of neurosensorial alterations. A distance of 1 mm from the mandibular canal might be safe. Implants placed at a distance less than 1 mm from the mandibular canal exhibit neurosensory alterations. Clinicians should be aware of the potential risk of nerve injury and adopt appropriate precautions, including meticulous preoperative planning and three-dimensional radiographic images.